Lexeo Therapeutics, Inc. · NASDAQ:LXEO

Affinity Asset Advisors, LLC reported a 8.40% stake in Lexeo Therapeutics, Inc. (Schedule 13G/A)

Event Jun 30, 2026 · Filed Aug 13, 2026

Affinity Asset Advisors, LLC reported a 8.40% stake in Lexeo Therapeutics, Inc., 6,674,913 shares, as a passive investor on Jun 30, 2026. Filed Aug 13, 2026 (Schedule 13G/A).

Stake
8.40%
Shares
6,674,913
Intent
Passive
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
Affinity Asset Advisors, LLC8.40%6,674,913
Michael Cho8.40%6,674,913

Source

View original at SEC

Related